Compare FEBO & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FEBO | BNGO |
|---|---|---|
| Founded | 1993 | 2003 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 11.6M |
| IPO Year | 2022 | 2018 |
| Metric | FEBO | BNGO |
|---|---|---|
| Price | $1.17 | $1.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 9.1K | ★ 88.7K |
| Earning Date | 04-24-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000,735.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.61 | $1.06 |
| 52 Week High | $1.48 | $5.50 |
| Indicator | FEBO | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 40.45 |
| Support Level | $1.04 | $1.07 |
| Resistance Level | $1.19 | $1.18 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 68.42 | 40.00 |
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.